You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美德納中國研發生產總部項目擬在滬開工建設 總投資36億人幣
阿思達克 11-07 07:29
據《中國證券報》從上海市經信委和閔行區政府獲悉,全球製藥巨企美國上市Moderna(莫德納公司)(MRNA.US)在內地首個藥廠-美德納中國研發生產總部項目昨日(6日)在上海開工建設。 該項目落地莘莊工業區,工業用地面積269.58畝,總投資約36億元人民幣,為截至目前全國生物醫藥領域投資額最大的標桿性外資項目。 作為上海生物醫藥領域重點項目,美德納公司為一家總部位於美國的跨國製藥及生物技術公司。自成立以來,已從一家推進信使核糖核酸(mRNA)領域項目的研究型公司轉變為一家擁有多樣化疫苗和治療藥物臨床組合企業。(ta/w) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account